Product Overview
Originating from South Korea’s advanced aesthetic research labs, REVOLAX has evolved into a globally trusted HA dermal filler solution distributed across over sixty nations since its formal international rollout, crafted exclusively for licensed aesthetic practitioners aiming for organic, long-lasting facial remodelling outcomesREVOLAX. Distinct from fragmented granular filler formulas dominating mainstream markets, the entire REVOLAX lineup adopts patented monophasic dense lattice gel construction, paired with 24mg/mL medical-grade cross-linked hyaluronic acid sourced via microbial fermentation without any animal-derived raw materials, plus 0.3% pharmaceutical-grade lidocaine pre-blended into every formulation to cut injection-related discomfort noticeably. All specifications follow physiological skin pH range (6.8–7.4), minimising epidermal irritation, redness and abnormal post-procedure puffiness; real-world clinical monitoring proves merely 8%–12% of recipients encounter mild transient swelling, far below the industry’s average 15%–20% swelling ratio of comparable filler goods. Each sterile single-use syringe holds 1.1ml filler content, paired with custom-sized fine injection needles matched to three core variants for targeted depth administration, with sealed unopened packaging boasting a full 24-month shelf life under regulated 2°C–25°C ambient storage conditions.
Core Formulation & Unique Technical Advantages
High-Purity Non-Animal HA Base Material
The core active ingredient is bio-fermented hyaluronic acid identical in molecular traits to HA naturally synthesised inside human dermis tissue, capable of trapping water up to one thousand times its own molecular weight to sustain persistent deep-layer skin hydration while prompting endogenous collagen regeneration inside treated regions, gradually improving overall skin texture long after initial injection treatmentREVOLAX. Controlled BDDE cross-linking craftsmanship locks HA molecular chains stably without extra free HA addition for formula calibration, slowing bodily enzymatic decomposition and stretching visible rejuvenation cycles drastically versus standard low-crosslink filler alternatives.
Optimised Viscoelastic Performance for Precise Sculpting
Tailored G’ elasticity coefficients are individually calibrated across Fine, Deep and Sub-Q lines to satisfy varied injection layer demands; moderate viscoelastic values grant ideal structural support for contour lifting while retaining flexible softness to blend seamlessly with surrounding native skin tissue, eliminating uneven lumping or unexpected filler migration issues post implantation. Practitioners benefit from reduced extrusion resistance during injection operations, lowering hand fatigue amid long-hour aesthetic appointments and drastically cutting syringe clogging incidents widely reported with rival filler products.
Low-Risk Biodegradable Design with Gradual Absorption
REVOLAX gel dissolves uniformly from outer molecular layers inward rather than splitting into irregular chunks during metabolism, ensuring consistent facial smoothness throughout the entire effect duration until complete natural breakdown and absorption inside human tissue without residual foreign substance buildup beneath the skin. Its refractive index closely mirrors real dermal optical properties, effectively avoiding unsightly bluish Tyndall-effect discoloration under thin periorbital and lip skin after filler placement.
Three Targeted Product Variants & Corresponding Treatment Indications
1. REVOLAX Fine
The lightest-viscosity option within the full portfolio, engineered for superficial dermal layer implantation (0.5–1.5mm beneath epidermis) with a usable effect lifespan spanning 9–12 months post-treatmentREVOLAX. Best suited for erasing fine surface creases including crow’s feet around eye corners, horizontal forehead tiny lines, glabellar frown marks between brows, faint neck wrinkles, subtle perioral fine lines, plus delicate natural lip plumping and trending Russian lip shaping requestsREVOLAX. Equipped with ultra-thin 30G injection needle to execute ultra-precise shallow injection for fragile thin-skin facial sections.
2. REVOLAX Deep
The brand’s most versatile mid-tier formulation crafted for mid-to-deep dermal layer injection (2.5–5mm depth), delivering sustained volumising results lasting between 12–18 months after single administration. Primary applicable scenarios include filling moderate-to-severe nasolabial smile folds, natural cheek padding enhancement, full lip augmentation, mild chin contour adjustment and temple hollow area restoration, fitted with standard 27G fine needle balancing injection precision and deep tissue penetration efficiencyREVOLAX.
3. REVOLAX Sub-Q
The highest-density, strongest-support variant made exclusively for deep subcutaneous tissue implantation, featuring peak structural rigidity to handle large-scale facial structural remodelling with identical 12–18 month service cycle as Deep versionREVOLAX. Ideal for prominent nose bridge refinement, pronounced chin augmentation, severe nasolabial groove correction, jawline definition shaping and substantial cheek volume replenishment; supplied with thicker 23G/25G needle to facilitate deep-layer bulk filler delivery for heavy contour reconstruction demands.
Suitable User Groups & Treatment Precautions
Perfect for adult clients aged above 25 suffering from natural HA depletion-triggered dry skin, progressive wrinkle formation and gradual facial volume loss, as well as beauty enthusiasts pursuing non-surgical minimally invasive facial feature optimisation without invasive plastic surgery downtime. All injection procedures must be completed by certified licensed medical aesthetic specialists; customers with active facial inflammatory conditions, autoimmune disorders, pregnancy or breastfeeding status are not eligible for filler injection treatments. After-care guidance includes avoiding high-temperature sauna, intense facial massage and strenuous workout within 72 hours following injection to secure optimal filler settling and final treatment outcomes.
Why Choose REVOLAX for Your Aesthetic Supply & Clinical Service?
Combining lab-verified safety credentials, stable long-lasting performance and cost-efficient pricing compared to high-end premium filler competitors, REVOLAX has earned consistent 92% positive feedback from global clinical users across multi-country follow-up tracking trials. Its all-in-one three-tier product layout covers full-spectrum facial rejuvenation requirements from faint fine-line smoothing to major structural facial sculpting, enabling beauty clinics to streamline filler stock procurement while satisfying diversified consumer aesthetic enhancement needs efficiently.
